Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA.

Clinical laboratory - 1 Jan 2002

Pfeifer K, Dobson C, Herron A, Kapprell H P

Abstract excerpt

The ABBOTT IMx HBsAg (V2) microparticle enzyme immunoassay (MEIA) is a fully automated two-step assay for the qualitative determination of hepatitis B surface antigen (HBsAg). HBsAg is the most important serological marker of acute and chronic hepatitis B infection. Therefore, sensitivity of the currently used detection systems for HBsAg is critical to blood screening, diagnosis of HBV infection and therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electronic Data Processing
Share to Hepatitis B
Share to Hepatitis B Surface Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Mutation

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 12146568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance characteristics of an improved version of the ABBOTT IMx HBsAg (V2) MEIA.PMID 12146568Read ↗

Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants.Semantic proximity Read ↗

An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).Semantic proximity Read ↗

Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.Semantic proximity Read ↗

Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.Semantic proximity Read ↗

An ultra-sensitive Abbott ARCHITECT® assay for the detection of hepatitis B virus surface antigen (HBsAg).Semantic proximity Read ↗

Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative/Confirmatory assays.Semantic proximity Read ↗

Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay.Semantic proximity Read ↗

Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.Semantic proximity Read ↗

Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays.Semantic proximity Read ↗

European collaborative evaluation of the enzygnost HBsAg 6.0 assay: Performance on hepatitis B virus surface antigen variantsSemantic proximity Read ↗

Performance characteristics of the COBAS AMPLICOR hepatitis C virus MONITOR Test, version 2.0.Semantic proximity Read ↗

Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.